Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference
CAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in the “RNA Medicines: Next-Generation RNA Therapeutics” panel at Chardan’s 10th Annual Healthcare Conference in New York City on Tuesday, October 20, 2026 at 9:45 a.m. ET.
Covered in this story
What has happened since
- Wave Life Sciences LTD is up 8.9% since this was published, 7 days ago.
- Atrium Therapeutics Inc is up 3.0% since this was published, 7 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $WVE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Wave Life Sciences LTD →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.